Human papillomavirus vaccines versus cervical cancer screening.

  title={Human papillomavirus vaccines versus cervical cancer screening.},
  author={Margaret Stanley},
  journal={Clinical oncology (Royal College of Radiologists (Great Britain))},
  volume={20 6},
Prophylactic vaccination with human papillomavirus (HPV) virus-like particle (VLP) vaccines against HPV 16 and HPV 18, which are the cause of 70% or more of cervical cancers in women, has transformed our prospects for reducing the incidence of this disease on a global scale. HPV VLP vaccines are immunogenic, well tolerated and show remarkable efficacy, achieving >98% protection in randomised clinical trials against the obligate precursor lesions cervical intraepithelial neoplasia grade 2/3… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 19 extracted citations

The HPV vaccine : a literature review examining the barriers to vaccination

Maggi Ann Bulla-Wallace
View 10 Excerpts
Highly Influenced

Priority Setting for Improvement of Cervical Cancer Prevention in Iran.

International journal of health policy and management • 2015

Gynecologic tumors: how to communicate imaging results to the surgeon

Cancer imaging : the official publication of the International Cancer Imaging Society • 2013
View 1 Excerpt


Publications referenced by this paper.
Showing 1-10 of 55 references

Similar Papers

Loading similar papers…